Anticancer effect of Kalpaamruthaa on mammary carcinoma in rats with reference to glycoprotein components, lysosomal

Krishnamurthy Veena1, Palanivelu Shanthi, Panchanatham Sachdanandam

  • 1Department of Medical Biochemistry, Dr. A. L. Mudaliar Post-Graduate Institute of Basic Medical Sciences, University of Madras, Chennai, India.

Insights

Kalpaamruthaa (KA), a herbal preparation, shows potential in cancer treatment by normalizing glycoprotein and enzyme levels in rats. The study identified 300 mg/kg body weight as an effective dosage for mammary carcinoma.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Dietary constituents and phytochemicals are explored for cancer chemoprevention.
  • Herbal preparations are investigated for their therapeutic potential against cancer.

Purpose of the Study:

  • To evaluate the anti-cancer efficacy of Kalpaamruthaa (KA), a herbal preparation.
  • To assess the impact of KA on glycoprotein components, marker enzymes, and lysosomal enzymes in a cancer model.

Main Methods:

  • Induced mammary carcinoma in Sprague-Dawley rats using 7,12-dimethylbenz(a)anthracene (DMBA).
  • Administered varying doses of KA (100-500 mg/kg BW) orally for 14 days post-induction.
  • Monitored changes in body weight, volume, glycoprotein levels, and enzyme activities.

Main Results:

  • KA administration normalized enzyme levels and body weight/volume changes in a dose-dependent manner.
  • Significant normalization was observed at a dosage of 300 mg/kg body weight.
  • KA demonstrated effectiveness in reducing markers associated with mammary carcinoma.

Conclusions:

  • Kalpaamruthaa (KA) exhibits significant anti-cancer properties.
  • The optimal effective dosage of KA for mammary carcinoma in this model is 300 mg/kg body weight.
  • KA represents a promising chemotherapeutic agent derived from dietary sources.